Brief: Adagene Announces Authorization Of Share Repurchase Program Up To Us$10 Million
29/06/2022 22:48
June 29 (Reuters) - Adagene Inc 978y.F :
* ADAGENE ANNOUNCES AUTHORIZATION OF SHARE REPURCHASE
PROGRAM UP
TO US$10 MILLION
Source text for Eikon: ID:nGNX8TfRxY
Further company coverage: 978y.F
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Adagene
See all newsBrief: Adagene To Begin Phase 1 Study Of ADG138 For Advanced Solid Tumors In Q4 2026
Brief: Adagene Announces That Third Arc Bio Has Selected First Lead Candidate Under Amended Strategic Collaboration For Development Of Masked Cd3 T Cell Engagers Utilizing Safebody® Technology
Brief: Adagene Inc Announces Offering Of American Depositary Shares
Brief: Adagene Announces FDA Fast Track Designation For Muzastotug (Adg126)
Brief: Adagene Expands SAFEBody Deal With Exelixis To Develop Third Novel Masked Antibody-Drug Conjugate